445 related articles for article (PubMed ID: 30526649)
21. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ;
Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079
[TBL] [Abstract][Full Text] [Related]
23. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
Pojskic L; Pojskic B
Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.
Brown EE; Byrne KH; Davis DM; McClellan R; Leucker T; Jones SR; Martin SS
J Clin Lipidol; 2020; 14(3):331-338. PubMed ID: 32220565
[TBL] [Abstract][Full Text] [Related]
25. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
[TBL] [Abstract][Full Text] [Related]
26. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populations.
Fourgeaud M; Lebreton L; Belabbas K; Di Filippo M; Rigalleau V; Couffinhal T; Pucheu Y; Barat P; Ged C; Bérard AM
J Clin Lipidol; 2022; 16(3):298-305. PubMed ID: 35379577
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
[TBL] [Abstract][Full Text] [Related]
30. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF
J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959
[TBL] [Abstract][Full Text] [Related]
31. Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia.
Jasani R; Ahmad Z; Schneider R; Tujardon C; Basit M; Khera A
J Clin Lipidol; 2022; 16(4):508-515. PubMed ID: 35568683
[TBL] [Abstract][Full Text] [Related]
32. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
[TBL] [Abstract][Full Text] [Related]
33. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
[TBL] [Abstract][Full Text] [Related]
34. Unusual genetic variants associated with hypercholesterolemia in Argentina.
Corral P; Geller AS; Polisecki EY; Lopez GI; Bañares VG; Cacciagiu L; Berg G; Hegele RA; Schaefer EJ; Schreier LE
Atherosclerosis; 2018 Oct; 277():256-261. PubMed ID: 30270055
[TBL] [Abstract][Full Text] [Related]
35. Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia.
Lorenzo A; Silva JDLD; James CE; Pereira AC; Moreira ASB
Arq Bras Cardiol; 2018 Feb; 110(2):119-123. PubMed ID: 29561990
[TBL] [Abstract][Full Text] [Related]
36. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
37. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
Sinan ÜY; Sansoy V
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype.
Medeiros AM; Alves AC; Miranda B; Chora JR; Bourbon M;
J Lipid Res; 2024 Feb; 65(2):100490. PubMed ID: 38122934
[TBL] [Abstract][Full Text] [Related]
39. Preliminary data of familial hypercholesterolemia (FH) patients in Romania.
Dumitrescu A; Mosteoru S; Vinereanu D; Dan GA; Gaita L; Gaita D
Atherosclerosis; 2018 Oct; 277():304-307. PubMed ID: 30270063
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
